Lawmakers weigh path to generic biologic drugs
617753
Cheaper versions of biologic drugs can be made safely, a U.S. Senate panel heard on Thursday, but brand-name makers of the pricey therapies for cancer and other diseases warned substitutes could be risky.
301219
The Thai government, which has clashed with Western pharmaceutical giants over expensive patented drugs, said Monday it is considering approving more cheap generic versions of pricey medicines.
757415
The future will bring generic competition for Lipitor's lucrative base of customers.
633491
The newly empowered Democrats' vow to  cut healthcare costs might spell bad news for the brand-name  pharmaceutical industry, but could provide new momentum for  generic drug rivals, the Wall Street Journal reported on its  Web site on Tuesday.
158083
The FDA is investigating Teva's generic version of Wellbutrin XL.
147168
The approval of a new drug is a long-term opportunity.
77107
Bloomberg - Dec. 8 (Bloomberg) -- House lawmakers are working to pass legislation to extend dozens of trade and tax benefits and preserve fees that Medicare pays doctors knowing that some senators may object when it gets to their chamber.
427635
Three drugs -- Vioxx, Ketek and Avandia -- are casting long shadows over the congressional debate on how to update and revise the 15-year-old system that has dramatically sped up the process of bringing prescription medicines to American consumers.
413899
Rising cost projections for the new Medicare drug benefit alarmed U.S. lawmakers on Wednesday and set off renewed calls to restrain spiraling drug prices and allow pharmaceutical imports from Canada.
700955
If the plans of the Turku-based company Biotie Therapies and the Californian Somaxon Pharmaceuticals work out, Americans could soon have access to a new medicine that is claimed to work against different types ...
252544
Republican congressional leaders struggled Wednesday to sidetrack legislation allowing prescription drugs to be imported from abroad, a pre-election controversy threatening to delay billion of dollars for homeland security.
602739
WASHINGTON -- Local biotech powerhouses were comforted by yesterday's congressional testimony that urged federal regulators to take a cautious approach to approving generic versions of biologics, including mandatory human clinical trials.
607555
Proposed legislation could spell changes across the pharmaceutical world.
415282
Members of the American Medical Association&#39;s House of Delegates during an annual meeting in Atlanta on Sunday debated whether to endorse the reimportation of lower-cost prescription drugs from Canada and some other nations, the AP/San Francisco Chronicle
9119
TORONTO (CP) - Canadians are paying hundreds of millions of dollars too much for generic prescription drugs because federal government policies are allowing manufacturers to shut out competitors, a study released Monday concludes.
66555
WASHINGTON - The bill Congress is soon expected to pass giving regulators more authority over pharmaceutical companies is most significant to biotech drug makers and their would-be generic rivals because of what was left out.
498720
A key U.S. lawmaker said on Thursday he had not yet seen a workable approach to creating an approval pathway for generic versions of expensive biotechnology medicines.